Vol. 7 No. 9 October - 2007

TABLE OF CONTENTS

Exploring the Properties of Gel-Matrix Technology
Christopher Adams believes the challenge in recent years has been to develop polymer systems that not only provide superior wear properties, but to achieve this in a manner that can be broadly applied to multiple compounds. 

Nanosuspensions as a Drug Delivery System: A Comprehensive Review

Tejal Shah, MPharm, Dharmesh Patel, MPharm, Jayshukh Hirani, MPharm, and Avani F. Amin, PhD, focus on various manufacturing and formulation perspectives and applications of nanosuspensions as a drug delivery system.

 

Mucoadhesive Buccal Drug Delivery: A Review

Vishnu M. Patel, PhD; Bhupendra G. Prajapati; and Karshanbhai M. Patel, MPharm; provide an overview of the oral mucosa and discuss recent literature on novel mucoadhesive polymers, buccal permeation enhancement, and protein and peptide delivery.

 

The Issues & Challenges Involved in In Vitro Release Testing for Semi-Solid Formulations

Qiuxi Fan, PhD; Mark Mitchnick, MD; and Andrew Loxley, PhD; discuss different IVRT set-ups for different systems of topical products and respective release profiles, as well as the challenges involved and how to solve them.

 

Oral Drug Delivery Technology ““ Delivering on Patient Expectations

Jeffrey H. Worthington, MBA, and David A. Tisi, MS, explain how properly formulated drug products that consider the aesthetics dimensions of patient acceptability will better serve the patient over the long-term and generate greater sales for the manufacturer and technology holder alike.

 

Catalent Pharma Solutions: A World Leading Provider of Advanced Drug Delivery Technologies & Services

Drug Delivery Executive: David Heyens, Senior Vice President, Global Sales, Catalent Pharma Solutions, discusses how Catalent helps companies find solutions to some of the key challenges facing the industry today.

 

Dow Corning: Going Beyond the Silicone Molecule

Drug Delivery Executive: Scott Fuson, Vice President for Specialty Chemicals, & Global Executive Director for the Life Sciences Industry for Dow Corning shares how his company is going beyond silicon-based technology, where it is the industry leader, to being a customer-focused partner, innovator, and solutions provider.

 

Intranasal Insulin – A Potential New Treatment Modality for Diabetes Mellitus

Robert M. Stote, MD, and Fred Feldman, PhD, suggest that with the evident benefits, and if the nasal mode of insulin delivery ultimately proves to be commercially effective, it could be a more reliable method of maintaining glycemic control.

 

Pharmaceuticals in India: A Business & Regulatory Outlook

Ames Gross, MBA, and John Minot caution that with a nontransparent regulatory system, fragmented geographic markets, and much local competition, India is not a place where easy success can be expected; however, its burgeoning economy, greater market openness, and the improved patent regime have altered the playing field.

 

Kalypsys: Focusing on the Complexities of Diseases

Executive Summary: Paul Grint, MD, CMO and Richard Heyman, PhD, Senior Vice President, Drug Discovery, Kalypsys, explain how their company is focused on building value through advancing existing and new programs and on establishing strategic partnerships.

 

DEPARTMENTS

 

Market News & Trends

 

Advanced Delivery Devices

A Review of Development & Design Technology for Next-Generation Dry Powder Inhalers

 

Technology Showcase

 

External Delivery

Whose Job Is It Anyway?

COVER

FEATURES